Peijia Medical Limited (HKG:9996)

Peijia Medical Statistics

Total Valuation

Peijia Medical has a market cap or net worth of HKD 3.82 billion. The enterprise value is 3.53 billion.

Market Cap	3.82B
Enterprise Value	3.53B

Important Dates

The next estimated earnings date is Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Peijia Medical has 668.65 million shares outstanding. The number of shares has decreased by -2.57% in one year.

Current Share Class	668.65M
Shares Outstanding	668.65M
Shares Change (YoY)	-2.57%
Shares Change (QoQ)	+0.97%
Owned by Insiders (%)	3.09%
Owned by Institutions (%)	19.81%
Float	419.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.22
PB Ratio	1.75
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	64.90
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.31
EV / Sales	4.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.44

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.16.

Current Ratio	1.79
Quick Ratio	1.43
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-1.04
Interest Coverage	-20.16

Financial Efficiency

Return on equity (ROE) is -10.96% and return on invested capital (ROIC) is -5.54%.

Return on Equity (ROE)	-10.96%
Return on Assets (ROA)	-5.04%
Return on Invested Capital (ROIC)	-5.54%
Return on Capital Employed (ROCE)	-9.83%
Revenue Per Employee	706,868
Profits Per Employee	-238,407
Employee Count	1,047
Asset Turnover	0.26
Inventory Turnover	1.30

Taxes

In the past 12 months, Peijia Medical has paid 6.83 million in taxes.

Income Tax	6.83M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.47% in the last 52 weeks. The beta is 0.39, so Peijia Medical's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+39.47%
50-Day Moving Average	7.00
200-Day Moving Average	5.96
Relative Strength Index (RSI)	31.54
Average Volume (20 Days)	1,472,543

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Peijia Medical had revenue of HKD 731.61 million and -246.75 million in losses. Loss per share was -0.37.

Revenue	731.61M
Gross Profit	506.67M
Operating Income	-230.18M
Pretax Income	-243.43M
Net Income	-246.75M
EBITDA	-162.16M
EBIT	-230.18M
Loss Per Share	-0.37

Balance Sheet

The company has 659.41 million in cash and 353.15 million in debt, giving a net cash position of 306.26 million or 0.46 per share.

Cash & Cash Equivalents	659.41M
Total Debt	353.15M
Net Cash	306.26M
Net Cash Per Share	0.46
Equity (Book Value)	2.18B
Book Value Per Share	3.24
Working Capital	399.15M

Cash Flow

In the last 12 months, operating cash flow was 58.83 million and capital expenditures -396.90 million, giving a free cash flow of -338.08 million.

Operating Cash Flow	58.83M
Capital Expenditures	-396.90M
Free Cash Flow	-338.08M
FCF Per Share	-0.51

Margins

Gross margin is 69.25%, with operating and profit margins of -31.46% and -33.73%.

Gross Margin	69.25%
Operating Margin	-31.46%
Pretax Margin	-33.27%
Profit Margin	-33.73%
EBITDA Margin	-22.16%
EBIT Margin	-31.46%
FCF Margin	n/a

Dividends & Yields

Peijia Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.57%
Shareholder Yield	2.57%
Earnings Yield	-6.46%
FCF Yield	-8.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4